
META Stock To $1,500?
Meta's AI investments are delivering tangible business results. The company's advertising revenue reached $46.6 billion in Q2 2025, up 21.5% year-over-year, with pricing growth continuing to propel the core business. Average price per ad increased 9% in the latest quarter, demonstrating Meta's ability to extract premium value from its AI-enhanced targeting capabilities.
The scale of AI integration is significant. Meta's generative AI tools are finding purchase with both users and advertisers, while the company's Llama models are supporting core ad ranking and content recommendations. This represents a fundamental shift from traditional social media advertising to AI-powered precision marketing.
While Meta stock holds promise, if you are looking for more stability than investing in an individual stock, consider the High Quality portfolio, which has surpassed the S&P, achieving >91% returns since its inception.
Key Growth Drivers
Path to Doubling
For Meta stock to double from current levels, the company needs consistent revenue growth of around 15-20% annually, along with margin expansion. This seems attainable through:
AI Monetization in Core Advertising:
Driving Engagement & User Growth:
Strategic Bets & New Revenue Streams:
Operational Efficiencies & Cost Management:
We anticipate Meta Platforms' revenues to surpass $265 billion within the next three years, with earnings likely to nearly double from under $24 per share in 2024 to over $45 per share in 2028, due to improved profitability. Currently, META stock trades around $780, pricing it at roughly 28 times its trailing earnings. This is considerably lower than some of its competitors, with Amazon trading at 39 times earnings and Microsoft at 41 times earnings.
Given Meta's deep integration of AI and its improving profitability, we foresee an upward revision in its valuation multiple. Even if the stock holds a similar valuation, it could exceed $1,300 within the next three to four years. If investors assign a higher multiple, it would signify more than a twofold increase from current levels. Also see – Meta's Valuation Ratios Comparison.
Potential Headwinds
The most significant risk is the intensifying competition in AI. Competition from cost-efficient solutions like DeepSeek raises questions about Meta's massive AI infrastructure investments and whether the company can maintain its technological moat.
Regulatory pressure on social media platforms could also limit Meta's ability to monetize user data and expand into new markets, particularly in Europe and Asia.
Finally, macroeconomic factors could influence Meta's performance. Economic recessions could curtail advertising investments across its platforms, including Facebook and Instagram. For more details, see – Buy or Sell META Stock? Moreover, high interest rates could render growth stocks like META less attractive than fixed-income options, potentially dampening investor enthusiasm.
Overall, Meta's path to doubling again depends on successfully monetizing its AI investments while achieving a Reality Labs inflection point. The company's dominant position in social media advertising, combined with aggressive AI infrastructure scaling, creates multiple avenues for sustained growth.
However, investors should recognize that reaching $1,500 per share would require Meta to demonstrate that its massive AI spending translates into sustainable competitive advantages and that Reality Labs can transition from a cost center to a growth driver. The opportunity exists, but execution risk remains high as competition intensifies across all of Meta's key markets. Now, we apply a risk assessment framework while building the 30-stock Trefis High Quality (HQ) Portfolio, which has a strong record of comfortably outperforming the S&P 500 over the past four years. Why is that? As a collective group, HQ Portfolio stocks have delivered superior returns with reduced risk compared to the benchmark index; less of a roller-coaster experience, as shown in HQ Portfolio performance metrics.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
9 minutes ago
- Yahoo
Hudbay Minerals (HBM) Climbs 15% on Stellar Earnings, $600-Million Investment From Mitsubishi
We recently published . Hudbay Minerals Inc. (NYSE:HBM) is one of the best-performing stocks on Wednesday. Hudbay Minerals grew its share prices for a second day on Wednesday, up 15.03 percent to close at $11.33 apiece, following an impressive earnings performance and a $600-million investment from Mitsubishi Corp. In its updated report, Hudbay Minerals Inc. (NYSE:HBM) said it swung to a net income attributable to shareholders of $117.7 million from an attributable net loss of $16.5 million in the same period last year, driven by higher gross margins and strong cost control. Revenues increased by 26 percent to $536.4 million from $425.5 million year-on-year. 'With the strong performance in the first half of the year, we are reaffirming our full year consolidated production guidance and are favourably tracking well below our full year consolidated cost guidance for 2025,' said Hudbay Minerals Inc. (NYSE:HBM) President and CEO Peter Kukielski. For the full-year period, the company is targeting to produce between 117,000 and 149,000 tons of copper, as well as 247,500 to 308,000 ounces of gold. In other news, Hudbay Minerals Inc. (NYSE:HBM) was able to raise $600 million in fresh funds from Mitsubishi Corp. after the latter acquired a 30-percent stake in Copper World LLC. Under the agreement, Mitsubishi will pay an upfront cash of $420 million, with the balance to serve as a matching contribution within an 18-month period. While we acknowledge the potential of HBM as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
9 minutes ago
- Yahoo
Paramount Skydance (PSKY) Soars 60% to New High. Time to Book Gains?
We recently published . Paramount Skydance Corp. (NASDAQ:PSKY) is one of the best-performing stocks on Wednesday. Paramount Skydance extended its rally to touch a new high on Wednesday, finishing up by 36.74 percent at $15 apiece, with a former hedge fund manager calling it a 'meme' stock. In a social media post, Mad Money host and former hedge fund manager Jim Cramer said Paramount Skydance Corp. (NASDAQ:PSKY) is a 'meme stock' given the company's small public float and unjustifiable rally amid the lack of fresh developments. Paramount Skydance Corp. (NASDAQ:PSKY) climbed by as high as 60 percent at intra-day trading to hit $17.53 before paring gains to finish slightly lower during the session. In recent news, the company bagged a new $7.7-billion deal to exclusively air the Ultimate Fighting Championship (UFC) on Paramount+ for seven years beginning in 2026. The deal would include UFC's full slate of 13 marquee numbered events and 30 Fight Nights through its direct-to-consumer streaming platform, Paramount+, with select numbered events to be simulcast on CBS. cellanr, CC BY-SA 2.0 , via Wikimedia Commons As part of the agreement, Paramount Skydance Corp. (NASDAQ:PSKY) will move UFC away from the existing Pay-Per-View model and make the latter available at no additional cost to Paramount+ subscribers in the US. It also intends to explore UFC rights outside the US in the future. While we acknowledge the potential of PSKY as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
9 minutes ago
- Yahoo
ImmunityBio (IBRX) Jumps 14% as on Promising Therapy Candidate Results
We recently published . ImmunityBio, Inc. (NASDAQ:IBRX) is one of the best-performing stocks on Wednesday. ImmunityBio soared by 14.17 percent on Wednesday to close at $2.82 apiece as investors cheered promising early findings from its ongoing trial (QUILT-106) to treat a rare blood cancer type with its therapy candidate. In a statement, ImmunityBio, Inc. (NASDAQ:IBRX) said the first phase of QUILT-106 showed highly promising results in the first two patients with Waldenstrom macroglobulinemia (WM)—a type of non-Hodgkins lymphoma (NHL)—using its CD19 CAR-NK (CD19 t-haNK) natural killer cell therapy. The trial aims to evaluate the safety and efficacy of the cell therapy alone, as well as when it is combined with an existing drug called rituximab. According to ImmunityBio, Inc. (NASDAQ:IBRX), both patients tolerated the therapy candidate without any significant side effects. Notably, all infusions were administered in an outpatient setting. Copyright: katrintimoff / 123RF Stock Photo 'One patient achieved a complete response (CR) with CD19 CAR NK monotherapy, while the second patient achieved CR with CD19 CAR-NK in combination with rituximab. Remission was maintained and is ongoing for six months to date,' ImmunityBio, Inc. (NASDAQ:IBRX) said. While we acknowledge the potential of IBRX as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data